cefixime has been researched along with Pharyngitis in 15 studies
Cefixime: A third-generation cephalosporin antibiotic that is stable to hydrolysis by beta-lactamases.
cefixime : A third-generation cephalosporin antibiotic bearing vinyl and (2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetamido groups at positions 3 and 7, respectively, of the cephem skeleton. It is used in the treatment of gonorrhoea, tonsilitis, pharyngitis, bronchitis, and urinary tract infections.
Pharyngitis: Inflammation of the throat (PHARYNX).
| Excerpt | Relevance | Reference |
|---|---|---|
| "In an open, controlled, randomized multicenter study, 160 children suffering from pharyngitis and/or tonsillitis were treated with either 8 mg cefixime/kg body weight once daily for 5 days or 20,000 I." | 9.08 | 5-day cefixime therapy for bacterial pharyngitis and/or tonsillitis: comparison with 10-day penicillin V therapy. Cefixime Study Group. ( Adam, D; Hostalek, U; Tröster, K, 1995) |
| "An open label randomized trial conducted in rural Kentucky compared the efficacy and safety of cefixime (CFX), 8 mg/kg once daily, with those of penicillin V (PEN), 250 mg 3 times daily, in 110 pediatric patients with Group A beta-hemolytic streptococcal pharyngitis." | 9.07 | Comparative study of the effectiveness of cefixime and penicillin V for the treatment of streptococcal pharyngitis in children and adolescents. ( Block, SL; Hedrick, JA; Tyler, RD, 1992) |
| "Cefixime, a new third generation oral cephalosporin antibiotic, was evaluated for safety and efficacy in the treatment of 206 children with acute bacterial pharyngitis, cystitis or pneumonia." | 9.06 | Noncomparative, open label, multicenter trial of cefixime for treatment of bacterial pharyngitis, cystitis and pneumonia in pediatric patients. ( Barone, JS; Clark, PA; Risser, WL; Simpkins, DL, 1987) |
| "In an open, controlled, randomized multicenter study, 160 children suffering from pharyngitis and/or tonsillitis were treated with either 8 mg cefixime/kg body weight once daily for 5 days or 20,000 I." | 5.08 | 5-day cefixime therapy for bacterial pharyngitis and/or tonsillitis: comparison with 10-day penicillin V therapy. Cefixime Study Group. ( Adam, D; Hostalek, U; Tröster, K, 1995) |
| "To compare, in a randomized controlled trial, the effectiveness of penicillin, cefixime and placebo on symptom resolution in patients presenting with a sore throat in general practice." | 5.08 | A randomized controlled trial of antibiotics on symptom resolution in patients presenting to their general practitioner with a sore throat. ( Brookes, S; Coast, J; Howe, RW; Millar, MR; Peters, TJ; Whitfield, M, 1997) |
| "An open label randomized trial conducted in rural Kentucky compared the efficacy and safety of cefixime (CFX), 8 mg/kg once daily, with those of penicillin V (PEN), 250 mg 3 times daily, in 110 pediatric patients with Group A beta-hemolytic streptococcal pharyngitis." | 5.07 | Comparative study of the effectiveness of cefixime and penicillin V for the treatment of streptococcal pharyngitis in children and adolescents. ( Block, SL; Hedrick, JA; Tyler, RD, 1992) |
| "Cefixime, a new third generation oral cephalosporin antibiotic, was evaluated for safety and efficacy in the treatment of 206 children with acute bacterial pharyngitis, cystitis or pneumonia." | 5.06 | Noncomparative, open label, multicenter trial of cefixime for treatment of bacterial pharyngitis, cystitis and pneumonia in pediatric patients. ( Barone, JS; Clark, PA; Risser, WL; Simpkins, DL, 1987) |
| "Influences of cefixime and cefaclor, oral antibiotics, were studied in 50 children (age range, 11 months to 13 years) with pharyngitis." | 3.68 | [Effects of cefixime and cefaclor on pharyngeal flora in children]. ( Maruyama, S; Sakata, H, 1991) |
| "Gonorrhea is a worldwide sexually transmitted disease (STD) caused by Neisseria gonorrhoeae." | 1.33 | Gonorrhea: update. ( Little, JW, 2006) |
| "Twenty-one pediatric patients with bacterial infections (10, tonsillitis; 4, pharyngitis; and 7, urinary tract infections) were treated with CFIX at doses of 1." | 1.27 | [Fundamental and clinical studies on cefixime in the pediatric field]. ( Hakamada, S; Hayakawa, F; Kuno, K; Miyachi, Y; Nakashima, S; Nakashima, T, 1986) |
| "Cefixime (CFIX) was evaluated for pharmacokinetics, therapeutic effectiveness on infection, safety, and bacteriological effectiveness in pediatrics." | 1.27 | [Fundamental and clinical studies on cefixime in pediatric field]. ( Kida, K; Matsuda, H; Miyazaki, M; Murase, M, 1986) |
| "In 9 cases of respiratory infections, therapeutic results were excellent in 3 cases, good in 6 cases, and the effective rate was 100%." | 1.27 | [Fundamental and clinical studies of cefixime in children]. ( Nakayama, N; Tsuji, Y; Yanagishima, M, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (26.67) | 18.7374 |
| 1990's | 7 (46.67) | 18.2507 |
| 2000's | 2 (13.33) | 29.6817 |
| 2010's | 1 (6.67) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Day, MJ | 1 |
| Jacobsson, S | 1 |
| Spiteri, G | 1 |
| Kulishev, C | 1 |
| Sajedi, N | 1 |
| Woodford, N | 1 |
| Blumel, B | 1 |
| van der Werf, MJ | 1 |
| Amato-Gauci, AJ | 1 |
| Unemo, M | 1 |
| Cole, MJ | 1 |
| Hartgill, U | 1 |
| Jakopanec, I | 1 |
| Vestrheim, DF | 1 |
| Rush, C | 1 |
| Simon, MW | 1 |
| Little, JW | 1 |
| Adam, D | 1 |
| Hostalek, U | 1 |
| Tröster, K | 1 |
| Davies, HD | 1 |
| Low, DE | 1 |
| Schwartz, B | 1 |
| Scriver, S | 1 |
| Fletcher, A | 1 |
| O'Rourke, K | 1 |
| Ipp, M | 1 |
| Goldbach, M | 1 |
| Lloyd, D | 1 |
| Saunders, NR | 1 |
| Howe, RW | 1 |
| Millar, MR | 1 |
| Coast, J | 1 |
| Whitfield, M | 1 |
| Peters, TJ | 1 |
| Brookes, S | 1 |
| Ogle, JW | 1 |
| Block, SL | 1 |
| Hedrick, JA | 1 |
| Tyler, RD | 1 |
| Di Nola, F | 1 |
| Arione, R | 1 |
| Bramato, C | 1 |
| Sakata, H | 1 |
| Maruyama, S | 1 |
| Risser, WL | 1 |
| Barone, JS | 1 |
| Clark, PA | 1 |
| Simpkins, DL | 1 |
| Nakashima, S | 1 |
| Hayakawa, F | 1 |
| Nakashima, T | 1 |
| Miyachi, Y | 1 |
| Hakamada, S | 1 |
| Kuno, K | 1 |
| Miyazaki, M | 1 |
| Kida, K | 1 |
| Matsuda, H | 1 |
| Murase, M | 1 |
| Nakayama, N | 1 |
| Yanagishima, M | 1 |
| Tsuji, Y | 1 |
1 review available for cefixime and Pharyngitis
| Article | Year |
|---|---|
[Cefixime. Microbiologic, kinetic and clinical profile].
Topics: Animals; Bacteria; Cefixime; Cefotaxime; Gonorrhea; Humans; Microbial Sensitivity Tests; Otitis Medi | 1991 |
6 trials available for cefixime and Pharyngitis
| Article | Year |
|---|---|
The effect of amoxicillin-clavulanate, cefixime and azithromycin on normal throat flora in children with group A streptococcal pharyngitis.
Topics: Amoxicillin-Potassium Clavulanate Combination; Azithromycin; Cefixime; Child; Child, Preschool; Dose | 2003 |
5-day cefixime therapy for bacterial pharyngitis and/or tonsillitis: comparison with 10-day penicillin V therapy. Cefixime Study Group.
Topics: Cefixime; Cefotaxime; Cephalosporins; Child; Child, Preschool; Female; Humans; Infant; Male; Penicil | 1995 |
Evaluation of short-course therapy with cefixime or rifampin for eradication of pharyngeally carried group A streptococci. The Ontario GAS Study Group.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Cefixime; Cefotaxime; Child; Drug Administration Schedule; | 1995 |
A randomized controlled trial of antibiotics on symptom resolution in patients presenting to their general practitioner with a sore throat.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Cefixime; Cefotaxime; Family Practice; Female; Humans; Mal | 1997 |
Comparative study of the effectiveness of cefixime and penicillin V for the treatment of streptococcal pharyngitis in children and adolescents.
Topics: Adolescent; Cefixime; Cefotaxime; Child; Child, Preschool; Female; Humans; Male; Penicillin V; Phary | 1992 |
Noncomparative, open label, multicenter trial of cefixime for treatment of bacterial pharyngitis, cystitis and pneumonia in pediatric patients.
Topics: Adolescent; Cefixime; Cefotaxime; Child; Child, Preschool; Clinical Trials as Topic; Cystitis; Diarr | 1987 |
8 other studies available for cefixime and Pharyngitis
| Article | Year |
|---|---|
Significant increase in azithromycin "resistance" and susceptibility to ceftriaxone and cefixime in Neisseria gonorrhoeae isolates in 26 European countries, 2019.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefixime; Ceftriaxone; Ciprofloxacin; Dr | 2022 |
[Gonorrhea--time for new guidelines].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cefixime; Ciprofloxacin; Drug Resistance, Bacterial; F | 2011 |
Gonorrhea: update.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Cefixime; Ceftriaxone; Child; Gonorrhea; Humans; Incidence | 2006 |
Antimicrobial therapy for ambulatory pediatrics.
Topics: Ambulatory Care; Anti-Bacterial Agents; Anti-Infective Agents; Cefixime; Cefuroxime; Cephalexin; Cep | 1999 |
[Effects of cefixime and cefaclor on pharyngeal flora in children].
Topics: Adolescent; Bacteria; Cefaclor; Cefixime; Cefotaxime; Child; Child, Preschool; Humans; Infant; Phary | 1991 |
[Fundamental and clinical studies on cefixime in the pediatric field].
Topics: Acute Disease; Bacteria; Bacterial Infections; Cefixime; Cefotaxime; Child; Child, Preschool; Female | 1986 |
[Fundamental and clinical studies on cefixime in pediatric field].
Topics: Acute Disease; Bacterial Infections; Cefixime; Cefotaxime; Child; Child, Preschool; Enteritis; Femal | 1986 |
[Fundamental and clinical studies of cefixime in children].
Topics: Administration, Oral; Adolescent; Cefixime; Cefotaxime; Child; Child, Preschool; Female; Humans; Inf | 1986 |